|
TATDN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.81628103854837E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.31620000746125E-09 |
| Normal-vs-Stage2 |
8.02830002477606E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
3.20679999998852E-07 |
| Stage1-vs-Stage2 |
9.675500E-02 |
| Stage1-vs-Stage3 |
1.623390E-04 |
| Stage1-vs-Stage4 |
4.726400E-01 |
| Stage2-vs-Stage3 |
3.869400E-01 |
| Stage2-vs-Stage4 |
4.111400E-01 |
| Stage3-vs-Stage4 |
5.895700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68554059598591E-12 |
| Normal-vs-AfricanAmerican |
1.461850E-03 |
| Normal-vs-Asian |
8.636300E-02 |
| Caucasian-vs-AfricanAmerican |
7.151600E-02 |
| Caucasian-vs-Asian |
3.212400E-01 |
| AfricanAmerican-vs-Asian |
9.284200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.0689673852512E-13 |
| Normal-vs-Female |
4.38009994940813E-09 |
| Male-vs-Female |
7.716200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.222700E-04 |
| Normal-vs-Age(41-60Yrs) |
9.81630332574923E-11 |
| Normal-vs-Age(61-80Yrs) |
2.79030132332991E-11 |
| Normal-vs-Age(81-100Yrs) |
2.42090000046602E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.505800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.207400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.877230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.955200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.244350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.751770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.534400E-01 |
| Normal-vs-Grade 2 |
3.89879994955322E-09 |
| Normal-vs-Grade 3 |
1.6251444634463E-12 |
| Normal-vs-Grade 4 |
3.84709999967647E-07 |
| Grade 1-vs-Grade 2 |
3.113700E-02 |
| Grade 1-vs-Grade 3 |
6.356700E-04 |
| Grade 1-vs-Grade 4 |
3.487500E-02 |
| Grade 2-vs-Grade 3 |
3.463500E-03 |
| Grade 2-vs-Grade 4 |
4.211400E-01 |
| Grade 3-vs-Grade 4 |
2.886000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.97597535292971E-12 |
| Normal-vs-ccB subtype |
3.84389964303011E-10 |
| ccA subtype-vs-ccB subtype |
3.095800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.18639575730617E-11 |
| Normal-vs-N1 |
4.477700E-02 |
| N0-vs-N1 |
6.395800E-01 |
|
|
